A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer
Clinical trial NCT03933982 · UNKNOWN
Trial details
- NCT number
- NCT03933982
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-22
- Primary completion
- 2021-12-22
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.